221. Anti-glomerular basement membrane disease
1 clinical trial,   3 drugs   (DrugBank: 1 drug),   0 gene,   0 pathway

Searched query = "Anti-glomerular basement membrane disease"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03157037
(ClinicalTrials.gov)
March 1, 201711/5/2017An Open-Label Phase II Study to Evaluate the Efficacy and Safety of IdeS in Anti-GBM Disease (GOOD-IDES)An Open-Label Phase II Study in Anti-GBM Disease (Goodpasture's Disease) With Adverse Renal Prognosis to Evaluate the Efficacy and Safety of IdeS --GOOD-IDESAnti-Glomerular Basement Membrane DiseaseBiological: HMed-IdeSMÃ¥rten SegelmarkHansa Biopharma ABCompleted18 YearsN/AAll15Phase 2Austria;Czechia;Denmark;France;Sweden